ARTICLE | Clinical News
Anti-dengue nanoviricides regulatory update
November 25, 2013 8:00 AM UTC
NanoViricides said the European Commission granted Orphan Drug designation for DengueCide to treat dengue and dengue hemorrhagic fever. The vaccine is in preclinical testing and has Orphan Drug design...